Trial Profile
Phase II Trial of Gleevec (Imatinib Mesylate) and Taxotere (Docetaxel) as a Combined Regimen for Advanced Gastric Adenocarcinoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2006
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Imatinib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 15 Nov 2006 Status change
- 06 Nov 2005 New trial record.